Hot off the presses! Just wanted to share our perspective piece on fibroblasts in pancreatic cancer! Great working with wifey Débora Vendramini-Costa, Ph.D and boss Howard Crawford to convey our mindset when working with CAFs. Hope it sparks discussion! CMGH
cmghjournal.org/article/S2352-…

National Volunteer Appreciation Week falls on April 21-27 📆, but we’re extending our gratitude to PanCAN volunteers throughout the month by highlighting a different volunteer each week! 💜 Meet #pancreaticcancer survivor Paul Cooper from our Survivor & Caregiver Network!

Paul…

Out in nature concurrent with #AACR24
Two papers on biochemistry and preclinical characterization of Revolution Medicines’ RAS(ON) multiRAS inhibitor, with a focus on #PancreaticCancer
KenOliveLab Ben Stanger Der Lab at UNC
nature.com/articles/s4158…
nature.com/articles/s4158…

Looking for a postdoc or staff scientist position to study metabolism and the systemic effects of cancer? Enjoy sun, beaches, hiking trails, sushi and tacos? We have multiple positions open. Join us today! sbpdiscovery.hrmdirect.com/employment/job… sbpdiscovery.hrmdirect.com/employment/job…

We are thrilled to announce clinical oncologist and drug developer, Anna Berkenblit, MD, MMSc, as our first-ever chief scientific and medical officer. In this new role, Dr. Berkenblit will oversee the current and future vision, strategy development, prioritization, and resource…

A comprehensive 5★ perspective/review on cancer as a complex, systemic disease with all the hallmarks cell.com/cell/fulltext/… Cell by Charles Swanton and colleagues

The frequency with which elite, peak fitness, top-of-their-game women tear their ACLs is astonishing. I hope there are people studying the physiology of this and how to lower the risk! 😢

Through our SPARK health data platform, we're breaking down barriers to #pancreaticcancer research by making real-world patient data accessible and easy-to-use for scientists across the country. 📊 This important work is making a difference: Two recent publications highlight how…

BREAKING NEWS! 📰📣The federal budget has finally been passed and funding for the Pancreatic Cancer Research Program at the Department of Defense was thankfully preserved despite budget constraints! 💜
This year’s budget includes $15M in dedicated pancreatic cancer research…

🔅ESMO-2023, hepatobiliary and pancreatic cancers
ESMO - Eur. Oncology EORTC

✅Biliary tract cancers

✔️Outcomes worse in extraheoatic CCA than intrahepatic with cis-gem
✔️tinengotinib as a FGFR2 inhibitor after progression with another FGFR inhibitor
✔️DESTINY-PanTumor02 trial,…

💜🥹💜

Angel City season opener!! Let’s go - volemos!! Angel City FC #AngelCityFC

We are so proud to share that #PanCANPurpleStride has ranked #23 on the 2023 U.S. Top 30 List of peer-to-peer fundraising programs, as published by the P2P Forum! 💜

Thank you to our striders, volunteers, fundraisers, donors, sponsors, staff, and more who made this achievement…

Join PanCAN in urging Congress to pass the federal budget NOW including $20M in dedicated #pancreaticcancer research funding! Take 2 mins to contact your members of Congress because patients need breakthroughs! p2a.co/vaOhD90

Tomorrow is my 14th anniversary of joining PanCAN, and these wonderful people are a huge reason why I've stayed so long 💜 Very grateful for an incredible team working together to improve #pancreaticcancer outcomes 💜

Allison Rosenzweig PanCAN Pam Acosta Marquardt Julie Fleshman Congratulations! 🎊🍾🎉

🧵 👇🏽

Happy 25th anniversary PanCAN 💜🩶 Huge gratitude to Pam Acosta Marquardt & Julie Fleshman for all the tremendous work you’ve done for people impacted by #pancreaticcancer 💜🩶

From clinical trial programs to molecular profiling services, learn how PanCAN has been changing the face of #pancreaticcancer research for over 20 years in our interview with Kawther Abdilleh, PhD: buff.ly/4bH72Tf